Efterpi Demiri

Efterpi Demiri

Auto-generated profile, based on publicly available information

Efterpi Demiri

Department of Plastic Surgery, School of Medicine, Aristotle University of Thessaloniki, GH Papageorgiou, Thessaloniki, Greece

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2016 in JCI Insight
Verified
Journal Article
Open access
PDF file
EGEpameinondas Gousopoulos
Epameinondas Gousopoulos
SPSteven T. Proulx
Steven T. Proulx
SBSamia B. Bachmann
Samia B. Bachmann
JSJeannette Scholl
Jeannette Scholl
DDDIMITRIOS DIONYSSIOU
DIMITRIOS DIONYSSIOU
MDMichael Detmar
Michael Detmar
Secondary lymphedema is a common postcancer treatment complication, but the underlying pathological processes are poorly understood and no curative treatment exists. To investigate lymphedema pathomechanisms, a top-down approach was applied, using genomic data and validating the role of a single target. RNA sequencing of lymphedematous mouse skin indicated upregulation of many T cell–related networks, and indeed depletion of CD4 + cells attenuated lymphedema. The significant upregulation of Foxp3, a transcription factor specifically expressed by regulatory T cells (Tregs), along with other Treg-related genes, implied a potential role of Tregs in lymphedema. Indeed, increased infiltration of Tregs was identified in mouse lymphedematous skin and in human lymphedema specimens. To investigate the role of Tregs during disease progression, loss-of-function and gain-of-function studies were performed. Depletion of Tregs in transgenic mice with Tregs expressing the primate diphtheria toxin receptor and green fluorescent protein ( Foxp3 -DTR-GFP) mice led to exacerbated edema, concomitant with increased infiltration of immune cells and a mixed T H 1/T H 2 cytokine profile. Conversely, expansion of Tregs using IL-2/anti–IL-2 mAb complexes significantly reduced lymphedema development. Therapeutic application of adoptively transferred Tregs upon lymphedema establishment reversed all of the major hallmarks of lymphedema, including edema, inflammation, and fibrosis, and also promoted lymphatic drainage function. Collectively, our results reveal that Treg application constitutes a potential new curative treatment modality for lymphedema.

9 April 2020 in Materials
Verified
Journal Article
Open access
PDF file
Leto-Aikaterini TzivelekaLeto-Aikaterini Tziveleka
Leto-Aikaterini Tziveleka
Andreas SapalidisAndreas Sapalidis
Andreas Sapalidis
SKStefanos Kikionis
Stefanos Kikionis
EAEleni Aggelidou
Eleni Aggelidou
EDEfterpi Demiri
Efterpi Demiri
Vassilios RoussisVassilios Roussis
Vassilios Roussis
Ulvan, a bioactive natural sulfated polysaccharide, and gelatin, a collagen-derived biopolymer, have attracted interest for the preparation of biomaterials for different biomedical applications, due to their demonstrated compatibility for cell attachment and proliferation. Both ulvan and gelatin have exhibited osteoinductive potential, either alone or in combination with other materials. In the current work, a series of novel hybrid scaffolds based on crosslinked ulvan and gelatin was designed, prepared and characterized. Their mechanical performance, thermal stability, porosity, water-uptake and in vitro degradation ability were assessed, while their morphology was analyzed through scanning electron microscopy. The prepared hybrid ulvan/gelatin scaffolds were characterized by a highly porous and interconnected structure. Human adipose-derived mesenchymal stem cells (hADMSCs) were seeded in selected ulvan/gelatin hybrid scaffolds and their adhesion, survival, proliferation, and osteogenic differentiation efficiency was evaluated. Overall, it was found that the prepared hybrid sponge-like scaffolds could efficiently support mesenchymal stem cells’ adhesion and proliferation, suggesting that such scaffolds could have potential uses in bone tissue engineering.

25 January 2018 in Aesthetic Plastic Surgery
Verified
Journal Article
Closed access
PDF file
EDEfterpi C. Demiri
Efterpi C. Demiri
DDDimitrios D. Dionyssiou
Dimitrios D. Dionyssiou
ATAntonios Tsimponis
Antonios Tsimponis
CGChristina-Olga Goula
Christina-Olga Goula
LPLeonidas C. Pavlidis
Leonidas C. Pavlidis
GSGeorgia-Alexandra Spyropoulou
Georgia-Alexandra Spyropoulou

Verified
Journal Article
Open access
PDF file
SKStefanos Kikionis
Stefanos Kikionis
Efstathia IoannouEfstathia Ioannou
Efstathia Ioannou
EAEleni Aggelidou
Eleni Aggelidou
Leto-Aikaterini TzivelekaLeto-Aikaterini Tziveleka
Leto-Aikaterini Tziveleka
EDEfterpi Demiri
Efterpi Demiri
Vassilios RoussisVassilios Roussis
Vassilios Roussis
Hybrid composites of synthetic and natural polymers represent materials of choice for bone tissue engineering. Ulvan, a biologically active marine sulfated polysaccharide, is attracting great interest in the development of novel biomedical scaffolds due to recent reports on its osteoinductive properties. Herein, a series of hybrid polycaprolactone scaffolds containing ulvan either alone or in blends with κ-carrageenan and chondroitin sulfate was prepared and characterized. The impact of the preparation methodology and the polysaccharide composition on their morphology, as well as on their mechanical, thermal, water uptake and porosity properties was determined, while their osteoinductive potential was investigated through the evaluation of cell adhesion, viability, and osteogenic differentiation of seeded human adipose-derived mesenchymal stem cells. The results verified the osteoinductive ability of ulvan, showing that its incorporation into the polycaprolactone matrix efficiently promoted cell attachment and viability, thus confirming its potential in the development of biomedical scaffolds for bone tissue regeneration applications.

1 January 2006 in Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery
Verified
Journal Article
Closed access
EDEfterpi Demiri
Efterpi Demiri
PFPericlis Foroglou
Periclis Foroglou
DDDimitrios Dionyssiou
Dimitrios Dionyssiou
AAAntonios Antoniou
Antonios Antoniou
PKParaskevas Kakas
Paraskevas Kakas
LLLampis Lazaridis
Lampis Lazaridis
We describe our experience with, and evaluate the reliability of, the lateral supramalleolar flap that was used in 20 patients for reconstruction of the distal leg and foot. There were 14 men and six women, age range 20-83 years. Nine were diabetic. The causes of the skin defects included trauma, diabetic ulcer, and deep burn. Sites of defects were the lower leg, the Achilles tendon, the dorsal and lateral aspect of the foot, and the ankle. Nineteen flaps survived and provided satisfactory coverage of the defect. Four flaps showed partial necrosis and required revision. We think that the lateral supramalleolar flap is a good way to reconstruct soft tissue defects of the lower extremity. Based on a secondary vascular axis, it has a large skin paddle and a wide rotation arc that reaches the distal areas of the foot.

6 September 2020 in Journal of Reconstructive Microsurgery
Verified
Journal Article
Closed access
PDF file
EDEfterpi C. Demiri
Efterpi C. Demiri
ATAntonios Tsimponis
Antonios Tsimponis
APAnastasios Pagkalos
Anastasios Pagkalos
EGEleni Georgiadou
Eleni Georgiadou
OGOlga-Christina Goula
Olga-Christina Goula
DDDimitrios Dionyssiou
Dimitrios Dionyssiou
Background The use of autologous tissues is considered the mainstay for delayed breast reconstruction. Aside the free abdominal flaps, which are most commonly used, the fat-augmented latissimus-dorsi (FALD) flap has been recently shown a reliable alternative option for pure autologous breast reconstruction. In this retrospective study, we aim to compare outcomes of autologous breast reconstructions using the extended FALD and deep inferior epigastric perforator flap (DIEP) flap, with an emphasis on patients' characteristics, demographic data, complications, and patients' satisfaction after a minimum 12-month follow-up. Methods Our series consists of 135 women who underwent a delayed postmastectomy unilateral autologous breast reconstruction from 2011 to 2017: 36 patients (Group A) had an extended FALD flap and 99 (Group B) a free DIEP flap performed by the same surgeons. Demographic data, breast volume, medical history, smoking, complications, and patients' satisfaction were recorded and analyzed. Student's t-test for independent variables, Mann–Whitney U-test, and Chi-squared test were used to compare the reported variables. Results Patients' age, body mass index (BMI), and pregnancy history were statistically different between groups (p < 0.001, p = 0.004, p < 0.001, respectively); younger age (35.1 vs. 41.2 years), lower BMI (25.6 vs. 28.4), and fewer pregnancies were recorded in Group A. Breast volume was also found significantly smaller in Group A patients (p = 0.009). Past medical history using the ASA physical status classification score, previous radiation therapy, history of smoking, and incidence of overall complications were similar in both groups. Overall satisfaction scores were found slightly higher, but not statistically significant, in the free-flap group (p = 0.442). Conclusion The use of the FALD flap may provide comparable outcome to the DIEP flap in delayed breast reconstruction in terms of complications and patients' satisfaction; it should be considered a good reconstructive option for young and thin nulliparous patients, with small to medium size opposite breast.